Dysregulation of iron protein expression in the G93A model of amyotrophic lateral sclerosis

Neuroscience

Volumn 230, Issue , 2013, Pages 94-101

  Hadzhieva, M ^a   Kirches, E ^a   Wilisch Neumann, A ^a   Pachow, D ^a   Wallesch, M ^a   Schoenfeld, P ^a   Paege, I ^a   Vielhaber, S ^a   Petri, S ^b   Keilhoff, G ^a   Mawrin, C ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Amyotrophic lateral sclerosis; Iron proteins

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; FRATAXIN; IRON; IRON REGULATORY FACTOR; IRON SULFUR PROTEIN; MESSENGER RNA; METALLOPROTEIN; MITOFERRIN 1; MITOFERRIN 2; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 1; REACTIVE OXYGEN METABOLITE; RETINOIC ACID; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BIOAVAILABILITY; CELL TRANSPORT; CONTROLLED STUDY; DMT1 GENE; FXN GENE; GENE; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC DAMAGE; HUMAN; HUMAN CELL; IRON RESPONSIVE ELEMENT; IRON TRANSPORT; IRP1 GENE; ISCU GENE; MFRN1 GENE; MFRN2 GENE; MITOCHONDRION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOD1 GENE; TFR1 GENE;

CATION TRANSPORT PROTEINS; CELL DIFFERENTIATION; CELL LINE, TUMOR; FLUORESCEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IRON; IRON-BINDING PROTEINS; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; NEUROBLASTOMA; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RECEPTORS, TRANSFERRIN; RNA, MESSENGER; SUPEROXIDE DISMUTASE; TRANSFECTION; TRETINOIN;

EID: 84871533864     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.11.021     Document Type: Article

References (33)

1. Ahtoniemi T., Jaronen M., Keksa-Goldsteine V., Goldsteins G., Koistinaho J. Mutant SOD1 from spinal cord of G93A rats is destabilized and binds to inner mitochondrial membrane. Neurobiol Dis 2008, 32:479-485.
2. Barber S.C., Shaw P.J. Oxidative stress in ALS: key role in motor neuron injury and therapeutic target. Free Radic Biol Med 2009, 48:629-641.
3. Bencze K.Z., Yoon T., Millan-Pacheco C., Bradley P.B., Pastor N., Cowan J.A., Stemmler T.L. Human frataxin: iron and ferrochelatase binding surface. Chem Commun (Camb) 2007, 14:1798-1800.
4. Beretta S., Sala G., Mattavelli L., Ceresa C., Casciati A., Ferri A., Carri M.T., Ferrarese C. Mitochondrial dysfunction due to mutant copper/zinc superoxide dismutase associated with amyotrophic lateral sclerosis is reversed by N-acetylcysteine. Neurobiol Dis 2003, 13:213-221.
5. Bridwell-Rabb J., Winn A.M., Barondeau D.P. Structure-function analysis of Friedreich's ataxia mutants reveals determinants of frataxin binding and activation of the Fe-S assembly complex. Biochemistry 2011, 50:7265-7274.
6. 2+ concentration in transfected neuroblastoma SH-SY5Y cells. FEBS Lett 1997, 414:365-368.
7. Carri M.T., Ferri A., Cozzolino M., Calabrese L., Rotilio G. Neurodegeneration in amyotrophic lateral sclerosis: the role of oxidative stress and altered homeostasis of metals. Brain Res Bull 2003, 61:365-374.
8. Casciati A., Ferri A., Cozzolino M., Celsi F., Nencini M., Rotilio G., Carri M.T. Oxidative modulation of nuclear factor-kappaB in human cells expressing mutant fALS-typical superoxide dismutases. J Neurochem 2002, 83:1019-1029.
9. Gille G., Reichmann H. Iron-dependent functions of mitochondria - relation to neurodegeneration. J Neural Transm 2011, 118:349-359.
10. Goldsteins G., Keksa-Goldsteine V., Ahtoniemi T., Jaronen M., Arens E., Akerman K., Chan P.H., Koistinaho J. Deleterious role of superoxide dismutase in the mitochondrial intermembrane space. J Biol Chem 2008, 283:8446-8452.
11. Hardiman O. Management of respiratory symptoms in ALS. J Neurol 2011, 258:359-365.
12. Jeong S.Y., Rathore K.I., Schulz K., Ponka P., Arosio P., David S. Dysregulation of iron homeostasis in the CNS contributes to disease progression in a mouse model of amyotrophic lateral sclerosis. J Neurosci 2009, 29:610-619.
13. Julien J.P., Kriz J. Transgenic mouse models of amyotrophic lateral sclerosis. Biochim Biophys Acta 2006, 1762:1013-1024.
14. Kamata H., Hirata H. Redox regulation of cellular signalling. Cell Signal 1999, 11:1-14.
15. Kayatekin C., Zitzewitz J.A., Matthews C.R. Disulfide-reduced ALS variants of Cu, Zn superoxide dismutase exhibit increased populations of unfolded species. J Mol Biol 2010, 398:320-331.
16. Koeppen A.H. Friedreich's ataxia: pathology, pathogenesis, and molecular genetics. J Neurol Sci 2011, 303:1-12.
17. Langkammer C., Enzinger C., Quasthoff S., Grafenauer P., Soellinger M., Fazekas F., Ropele S. Mapping of iron deposition in conjunction with assessment of nerve fiber tract integrity in amyotrophic lateral sclerosis. J Magn Reson Imaging 2010, 31:1339-1345.
18. Milani P., Gagliardi S., Cova E., Cereda C. SOD1 transcriptional and posttranscriptional regulation and its potential implications in ALS. Neurol Res Int 2011, 458427.
19. Mizuno Y., Amari M., Takatama M., Aizawa H., Mihara B., Okamoto K. Transferrin localizes in Bunina bodies in amyotrophic lateral sclerosis. Acta Neuropathol 2006, 112:597-603.
20. Orino K., Lehman L., Tsuji Y., Ayaki H., Torti S.V., Torti F.M. Ferritin and the response to oxidative stress. Biochem J 2001, 357:241-247.
21. Ouyang Q., Bommakanti M., Miskimins W.K. A mitogen-responsive promoter region that is synergistically activated through multiple signalling pathways. Mol Cell Biol 1993, 13:1796-1804.
22. Pahl H.L. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 1999, 18:6853-6866.
23. Panov A., Kubalik N., Zinchenko N., Hemendinger R., Dikalov S., Bonkovsky H.L. Respiration and ROS production in brain and spinal cord mitochondria of transgenic rats with mutant G93a Cu/Zn-superoxide dismutase gene. Neurobiol Dis 2011, 44:53-62.
24. Paradkar P.N., Roth J.A. Nitric oxide transcriptionally down-regulates specific isoforms of divalent metal transporter (DMT1) via NF-kappaB. J Neurochem 2006, 96:1768-1777.
25. Paradkar P.N., Zumbrennen K.B., Paw B.H., Ward D.M., Kaplan J. Regulation of mitochondrial iron import through differential turnover of mitoferrin 1 and mitoferrin 2. Mol Cell Biol 2009, 29:1007-1016.
26. Richardson D.R., Huang M.L., Whitnall M., Becker E.M., Ponka P., Suryo Rahmanto Y. The ins and outs of mitochondrial iron-loading: the metabolic defect in Friedreich's ataxia. J Mol Med (Berl) 2009, 88:323-329.
27. Riemer J., Hoepken H.H., Czerwinska H., Robinson S.R., Dringen R. Colorimetric ferrozine-based assay for the quantitation of iron in cultured cells. Anal Biochem 2004, 331:370-375.
28. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J.P., Deng H.X. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993, 362:59-62.
29. Salvador G.A., Oteiza P.I. Iron overload triggers redox-sensitive signals in human IMR-32 neuroblastoma cells. Neurotoxicology 2011, 32:75-82.
30. Schmucker S., Martelli A., Colin F., Page A., Wattenhofer-Donze M., Reutenauer L., Puccio H. Mammalian frataxin: an essential function for cellular viability through an interaction with a preformed ISCU/NFS1/ISD11 iron-sulfur assembly complex. PLoS One 2011, 6:e16199.
31. Shaw G.C., Cope J.J., Li L., Corson K., Hersey C., Ackermann G.E., Gwynn B., Lambert A.J., Wingert R.A., Traver D., Trede N.S., Barut B.A., Zhou Y., Minet E., Donovan A., Brownlie A., Balzan R., Weiss M.J., Peters L.L., Kaplan J., Zon L.I., Paw B.H. Mitoferrin is essential for erythroid iron assimilation. Nature 2006, 440:96-100.
32. Turner B.J., Talbot K. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS. Prog Neurobiol 2008, 85:94-134.
33. Wang Q., Zhang X., Chen S., Zhang X., Zhang S., Youdium M., Le W. Prevention of motor neuron degeneration by novel iron chelators in SOD1(G93A) transgenic mice of amyotrophic lateral sclerosis. Neurodegener Dis 2011, 8:310-321.